Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fobi AI is a Canadian public technology company that provides AI, data intelligence, and mobile wallet software for enterprise digital transformation. Its core offerings center on wallet pass infrastructure, real-time analytics, customer engagement, and implementation services used across industries including retail, sports, hospitality, regulated sectors, and selected healthcare use cases. In healthcare, Fobi markets digital patient engagement and administrative workflow tools such as wallet-based appointment reminders, test results, and secure access credentials, but it is not a drug-development or therapeutic biotech company. The company appears to operate primarily as a commercial software and services business rather than a life sciences innovator with a therapeutic pipeline. For biotech or pharma diligence purposes, Fobi is better classified as a horizontal enterprise technology vendor with some healthcare applications than as a healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fobi AI.